# Metformin Continuation Versus Interruption Following Coronary Angiography: a Pilot Randomized Controlled Trial

> **NCT03980990** · PHASE4 · UNKNOWN · sponsor: **University of Saskatchewan** · enrollment: 500 (estimated)

## Conditions studied

- Acute Coronary Syndrome
- Unstable Angina
- Diabetes Mellitus
- Metformin Adverse Reaction

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT03980990
- **Lead sponsor:** University of Saskatchewan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-17
- **Primary completion:** 2020-06-17
- **Final completion:** 2020-06-17
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2019-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03980990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03980990, "Metformin Continuation Versus Interruption Following Coronary Angiography: a Pilot Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03980990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*